Rising Regulatory Issues Will Hinder International Expansion And Fee Margins
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 17 Analysts
Published
23 Jun 25
Updated
20 Aug 25
AnalystLowTarget's Fair Value
US$124.85
44.5% overvalued intrinsic discount20 Aug
US$180.45
1Y
187.6%7D
3.3%